Skip to main content
. 2022 Jun 10;23(12):6527. doi: 10.3390/ijms23126527

Table 1.

Genes reported to alter depending on osteoarthritis (OA) pathology.

Gene Name Normal Chondrocyte Cell (vs. OA-Induced Cell) Predicted Alterations by Secretome
vs. Literature $
Reference
MMP3 Mat. [25,26]
MMP13 Mat. [20]
ADAMTS5 Opp. [25]
Caspase9 Mat. [27]
Bax Mat. [28,29]
Bcl-2 N.C Mat. [30]
COL2a1 + Mat. [23,25]
ACAN + Mat. [23]
SOX9 + N.D [23]
HIF1α + Opp. [31]
TNFα Mat. [32]
IL-1β N.D [33]
IL-4 + Mat. [34]
TGFβ Mat. [24]
COL1a1 Opp. [23]
BMP2 N.D [23]
RUNX2 Opp. [23,35]
COL10a1 N.D [23,36]
IHH Mat. [23,37]
DKK1 + N.D [23,38,39]
FRZB + N.D [23]
GREM1 +(early)/−(late) N.D [23]
AXIN2 N.D [23]
TIMP1 + Mat.
IL-6 Mat. [21,22,40]
LIF N.D
IL-17 Mat. [33]
MMP1 Mat. [20,25]
NF-kB Opp. [22,41]
STAT3 Opp. [21,42]

¶, The expression levels of genes in normal chondrocyte cells compared to osteoarthritis-differentiated cells reported in the literature. + indicates that the gene level was higher in normal cells than in OA-differentiated cells. − indicates the opposite case. $, Comparison between the expression levels in normal chondrocytes reported by other studies and the predicted levels based on our secretome profile using IPA tool; N.C., no change; Mat., IPA-predictions matched to literature; Opp., IPA-prediction contradictory the literature; N.D., no decision.